Cargando…

Geographical origin of chronic Chagas disease patients in Brazil impacts the performance of commercial tests for anti-T. cruzi IgG

BACKGROUND: Chagas disease, caused by Trypanosoma cruzi, affects nearly six million people worldwide. Various serological tests have been developed for its diagnosis. OBJECTIVE: Examine the performance of a set of commercial immunological assays in relation to the geographical origin of the patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sáez-Alquezar, Amadeo, Junqueira, Angela Cristina Verissimo, Durans, Andressa da Matta, Guimarães, André Valpassos, Corrêa, José Abol, Borges-Pereira, José, Zauza, Patrícia Lago, Cabello, Pedro Hernan, Albajar-Viñas, Pedro, Provance, David William, Coura, José Rodrigues
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Oswaldo Cruz, Ministério da Saúde 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168343/ http://dx.doi.org/10.1590/0074-02760210032

Ejemplares similares

Application of WHO International Biological Reference Standards to evaluate commercial serological tests for chronic Chagas disease
por: Sáez-Alquezar, Amadeo, et al.
Publicado: (2020)

Quality Control in Screening for Infectious Diseases at Blood Banks. Rationale and Methodology
por: Sáez-Alquezar, Amadeo, et al.
Publicado: (2015)

Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries
por: Coura, José Rodrigues, et al.
Publicado: (2014)

Chagas disease in Virgem da Lapa, Minas Gerais, Brazil: left ventricle aneurysm and the risk of death in the 24-year interval
por: Borges-Pereira, José, et al.
Publicado: (2020)

Nicastrin-Like, a Novel Transmembrane Protein from Trypanosoma cruzi Associated to the Flagellar Pocket
por: Lechuga, Guilherme Curty, et al.
Publicado: (2021)

Morbidity of Chagas heart disease in the microregion of Rio Negro, Amazonian Brazil: a case-control study
por: Coura, José Rodrigues, et al.
Publicado: (2013)

A new survey of the serology of human Trypanosoma cruzi infection in the Rio Negro microregion, Brazilian Amazon: a critical analysis
por: Coura, José Rodrigues, et al.
Publicado: (2013)

Acute Chagas disease in the state of Pará, Amazon Region: is it increasing?
por: dos Santos, Valéria Regina Cavalcante, et al.
Publicado: (2018)

Surveillance, health promotion and control of Chagas disease in the Amazon Region - Medical attention in the Brazilian Amazon Region: a proposal
por: Coura, José Rodrigues, et al.
Publicado: (2015)

Surveillance of seroepidemiology and morbidity of Chagas disease in the Negro River, Brazilian Amazon
por: Coura, José Rodrigues, et al.
Publicado: (2018)

Special issue on Chagas disease
por: Coura, José Rodrigues
Publicado: (2015)

Chagas disease-specific antigens: characterization of epitopes in CRA/FRA by synthetic peptide mapping and evaluation by ELISA-peptide assay
por: Bottino, Carolina G, et al.
Publicado: (2013)

Chagas disease: control, elimination and eradication. Is it possible?
por: Coura, José Rodrigues
Publicado: (2013)

Health Policies to Control Chagas Disease Transmission in European Countries
por: Requena-Méndez, Ana, et al.
Publicado: (2014)

A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention
por: Machado-de-Assis, Girley Francisco, et al.
Publicado: (2013)

Congenital Chagas Disease: Recommendations for Diagnosis, Treatment and Control of Newborns, Siblings and Pregnant Women
por: Carlier, Yves, et al.
Publicado: (2011)

Clinical Follow-Up of Responses to Treatment with Benznidazol in Amazon: A Cohort Study of Acute Chagas Disease
por: Pinto, Ana Yecê das Neves, et al.
Publicado: (2013)

The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions - A comprehensive review
por: Coura, José Rodrigues
Publicado: (2015)

Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients
por: Ramírez, Juan David, et al.
Publicado: (2010)

Preanalytical Nonconformity Management Regarding Primary Tube Mixing in Brazil
por: Lima-Oliveira, Gabriel, et al.
Publicado: (2017)

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023)

Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018
por: Guggenbühl Noller, Jessica Michelle, et al.
Publicado: (2020)

Meiotic sex in Chagas disease parasite Trypanosoma cruzi
por: Schwabl, Philipp, et al.
Publicado: (2019)

Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease
por: Macedo, Andréa M, et al.
Publicado: (2022)

Trypanosoma cruzi and Chagas disease: diversity, progress and challenges
por: Miles, Michael A
Publicado: (2022)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection
por: Arce-Fonseca, Minerva, et al.
Publicado: (2018)

Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease
por: da Costa, Kelli Monteiro, et al.
Publicado: (2021)

Chagas Disease: Detection of Trypanosoma cruzi by a New, High-Specific Real Time PCR
por: Kann, Simone, et al.
Publicado: (2020)

The Parasite Load of Trypanosoma cruzi Modulates Feeding and Defecation Patterns of the Chagas Disease Vector Triatoma infestans
por: Chacón, Francisco, et al.
Publicado: (2022)

Human Chagas-Flow ATE-IgG1 for advanced universal and Trypanosoma cruzi Discrete Typing Units-specific serodiagnosis of Chagas disease
por: Alessio, Glaucia Diniz, et al.
Publicado: (2020)

Adding a piece to the puzzle of Latin American blood donors and the potential risk of Trypanosoma cruzi transmission in Germany
por: Ullrich, Julian, et al.
Publicado: (2022)

Comparative evaluation of community interventions for the immigrant population of Latin American origin at risk for Chagas disease in the city of Barcelona
por: Gómez i Prat, Jordi, et al.
Publicado: (2020)

Human acute Chagas disease: changes in factor VII, activated protein C and hepatic enzymes from patients of oral outbreaks in Pará State (Brazilian Amazon)
por: dos Santos, Valéria Regina Cavalcante, et al.
Publicado: (2020)

SEROPREVALENCE OF T. cruzi INFECTION IN BLOOD DONORS AND CHAGAS CARDIOMYOPATHY IN PATIENTS FROM THE COAL MINING REGION OF COAHUILA, MEXICO
por: Martínez-Tovar, José Gerardo, et al.
Publicado: (2014)

Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Médecins Sans Frontières
por: Yun, Oliver, et al.
Publicado: (2009)

Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy
por: Hovsepian, Eugenia, et al.
Publicado: (2012)

Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease
por: Wang, Wei, et al.
Publicado: (2021)

Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease
por: Zingales, Bianca, et al.
Publicado: (2022)

Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution
por: Talvani, André, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ifnbabtqqbiao6to36njugocid